Tagged With Vaccine

We could see promising vaccine data before the election

Goldman Sachs lifts 2021 US GDP forecast to 6.2% and predicts a COVID-19 vaccine will be 'widely distributed' by mid-2021

Just 30% of Brits say they would definitely get a coronavirus vaccine, with scientists blaming anti-vaxxer conspiracy theories and mistrust in government

Bill Gates thinks the COVID-19 pandemic won't be over until the end of 2021, even for the world's richest countries

2 charts from a top Wall Street bank reveal how drugmakers could deliver a coronavirus vaccine October surprise for Trump

Trump claims a coronavirus vaccine will be ready 'right around' the November election, contradicting Fauci's prediction

Goldman Sachs says investors are underestimating the chance of a COVID-19 vaccine in 2020, an event that could push the S&P 500 11% higher

Novavax skyrockets 23% after saying its COVID-19 vaccine showed promising results in an early trial

Hospitals in Beirut were so badly damaged by the explosion that many can't admit new patients

Fauci: The US isn't sacrificing safety in the race for a vaccine

Russia is aiming for an approved COVID-19 vaccine in the next fortnight to portray itself as a global science leader, but there are major concerns over a lack of data and testing

We just got one step closer to finding out whether leading coronavirus vaccines work

The coronavirus vaccine from Sanofi and GlaxoSmithKline will receive up to $2.1 billion from Operation Warp Speed — here's how it compares to other candidates

Pfizer CEO defends the idea of companies profiting off coronavirus vaccines

The head of China's CDC says he got injected with an experimental coronavirus vaccine to show that people shouldn't fear it

Moderna's coronavirus vaccine just started its phase 3 trial — the first in the US. Here's how it will work.

The bright spot in Trump's coronavirus response

The Trump administration will shell out $2 billion toward the creation of a coronavirus vaccine, and the first 100 million doses will be free to Americans

Pfizer, BioNTech surge after the US government orders 100 million doses of COVID-19 vaccine

The economic hit from COVID-19 will be felt 'for a long time' even if a vaccine is ready in 2020, a top economist warned